Optimal analgesia with remifentanil for patients requiring postoperative intensive care.

Optimal analgesia with remifentanil for patients requiring postoperative intensive care. - I-pooR

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051558

Enrollment

Registered

2023-07-20

Start date

2023-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Admission to the Surgical Intensive Care Unit (SICU) after surgery under general anesthesia.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are at least 20 years of age at the time consent is obtained and who will be admitted to the SICU after surgery under general anesthesia. 2. Cases of observation arterial pressure measurement by radial artery. 3. Cases with consent for this study.

Exclusion criteria

Exclusion criteria: A) Cases with atrial fibrillation. B) Cases in which it is inappropriate to perform the observation arterial manometry in the radial artery. C) Patients with significant hemodynamic or neurologic impairment in the upper extremities. D) Patients with severe stenosis or occlusive lesions in cerebral vessels. E) Cases with contraindications to remifentanil, propofol, or rocuronium. F) Patients who are regularly using opioids. G) Cases in which prior consent has been withdrawn. H) Cases in which the anesthesiologist deems the patient unfit to perform this study.

Design outcomes

Primary

Measure	Time frame
Correlation between MECK and remifentanil dosage	—

Secondary

Measure	Time frame
Time required for remifentanil dosing rate to stabilize.	—

Countries

Japan

Contacts

Public ContactSatoshi Kamiya

Graduate School of Biomedical Sciences, Hiroshima University Department of Anesthesiology and Critical Care

satobo-kamiya@hiroshima-u.ac.jp082-257-5555

Outcome results